packageFremanezumab

fremanezumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Fremanezumab is a monoclonal antibody used to prevent migraine, including migraine with and without aura. It is an approved CGRP-antagonist medicine authorised in the European Union for migraine prevention.

Summary written by glm-5.3-flash from Wikidata Q39048381 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:fremanezumab
ATC codes:N02CD03
DrugBank:DB14041
Wikidata:Q39048381
molar mass:148000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown